Ortec International
News from Ortec International highlights the most recent developments
Published in Medical Patent Business Week, November 24th, 2006
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Ortec International.
Report 1: Ortec International, Inc. (OTCI) announced that a preliminary review of the un-audited data of all the patients treated in its recently completed confirmatory trial indicates OrCel healed more wounds and achieved 100% wound closure of those wounds sooner in comparison to the control group.
Statistical significance was achieved for the primary clinical endpoints of incidence of patients achieving 100% wound closure as well as...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Business Week
More Articles from Medical Patent Business Week
- Business & Finance
Cytokinetics reports third quarter 2006 financial results and clinical highlights - Business & Finance
Enpath Medical reports 22% increase in third quarter revenues - Business Update
QLT announces third quarter results for 2006, updates guidance and implements cost reductions - Business Update
UTEK Corporation and GammaCan International sign strategic alliance agreement - Collaborations
Orexo announces collaboration with Doxa - Complementary & Alternative Medicine
Leading cancer researchers take closer look at much-in-demand maitake mushroom - More from this issue of Medical Patent Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
